Caroline Xie is a General Partner at ICONIQ Growth investing in software, healthcare, and internet companies. During her tenure at ICONIQ, she has managed over $1.7 billion in investments, particularly within the healthcare space, including Benchling, DexCare, Komodo Health, Nayya, Notable, Twin Health and Unite Us, among others. Prior to ICONIQ, Caroline was an investment banker in the finance and healthcare sectors for Morgan Stanley in Hong Kong and California.